Travere stock surges 44% on FDA approval for rare kidney disease

Travere stock surges 44% on FDA approval for rare kidney diseaseSource: Investing.com
أخبار الاستثمار والأسواق المالية من موقع Investing.com

Travere stock surges 44% on FDA approval for rare kidney diseaseSource: Investing.com
Goldman Sachs cuts Worldline to “sell” on weak cash flow outlookSource: Investing.com

Wells Fargo profit rises on interest income, trading boostSource: Reuters

Lucid stock surges on $750M investment, expanded Uber dealSource: Investing.com

Analysis-Investors size up landmark new chapter for Hungary post-OrbanSource: Reuters

UBS: Rate hike expectations may be overestimated amid energy shockSource: Investing.com

US stock futures climb as traders cling to de-escalation hopes, await earningsSource: Reuters

CATL eyes $5 billion Hong Kong share sale, Reuters reportsSource: Investing.com

BMW deliveries slide in Q1 as China, US weakness outweighs Europe growthSource: Reuters

Continental shares jump as Barclays upgrades on ’defensive’ appealSource: Investing.com